Gossamer Bio Inc

GOSS

Get informed when a big investor buys or sells

Market Cap$41.75M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Gossamer Bio Inc	-0.2	-	133%	-	-0.4

$0.08

Current Fair Value

52.7% downside

Overvalued by 52.7% based on the discounted cash flow analysis.

Share Statistics

Market cap	$41.75 Million
Enterprise Value	$39.71 Million
Dividend Yield	$- (-)
Earnings per Share	$-0.75
Beta	2.05
Outstanding Shares	234,137,364

Return

Return on Equity	133.17%
Return on Assets	-162.91%
Return on Invested Capital	347.21%

Valuation & Multiples

P/E Ratio	-0.23
PEG	0.16
Price to Sales	-
Price to Book Ratio	-0.17
Enterprise Value to Revenue	0.75
Enterprise Value to EBIT	-0.19
Enterprise Value to Net Income	-1
Total Debt to Enterprise	0.98
Debt to Equity	-0.42

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

August 13, 2026

EPS Estimate

$-0.12

Average shareholder expectation

Revenue Estimate

$3.63 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.1819▼ 14.36%
Total Calls	2,843,300▼ 53.69%
Total Puts	517,300▼ 74.12%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	71.34%▼ 9.61%
Total Invested	$55.40M▼ 90.34%
Investors Holding	199▼ 18.00%

ESG Score